Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Walsh is an analyst at B. Riley Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 25.72% | Justin Walsh41% | $127 → $122 | Maintains | Buy | Get Alert |
| 03/11/2025 | SER | Buy Now | Serina Therapeutics | $4.85 | 126.8% | Justin Walsh41% | → $11 | Initiates | → Buy | Get Alert |
| 12/16/2024 | ANRO | Buy Now | Alto Neuroscience | $2.37 | 659.49% | Justin Walsh41% | → $18 | Initiates | → Buy | Get Alert |
| 10/18/2024 | RAPP | Buy Now | Rapport Therapeutics | $9.70 | 332.99% | Justin Walsh41% | → $42 | Initiates | → Buy | Get Alert |
| 10/11/2024 | THTX | Buy Now | Theratechnologies | $1.60 | — | Justin Walsh41% | — | Downgrade | Buy → Hold | Get Alert |
| 09/04/2024 | BLRX | Buy Now | BioLine Rx | $3.17 | -36.91% | Justin Walsh41% | → $80 | Initiates | → Buy | Get Alert |
| 07/25/2024 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 50.45% | Justin Walsh41% | $105 → $146 | Maintains | Buy | Get Alert |
| 07/19/2024 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 41.18% | Justin Walsh41% | $128 → $137 | Maintains | Buy | Get Alert |
| 07/11/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.96 | 363.71% | Justin Walsh41% | → $23 | Initiates | → Buy | Get Alert |
| 05/16/2024 | CATX | Buy Now | Perspective Therapeutics | $2.38 | -7.56% | Justin Walsh41% | $15 → $22 | Maintains | Buy | Get Alert |
| 05/10/2024 | TLSI | Buy Now | TriSalus Life Sciences | $5.30 | 201.89% | Justin Walsh41% | → $16 | Initiates | → Buy | Get Alert |
| 04/18/2024 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 2.02% | Justin Walsh41% | $95 → $99 | Maintains | Buy | Get Alert |
| 04/17/2024 | ACHV | Buy Now | Achieve Life Sciences | $2.90 | 589.66% | Justin Walsh41% | → $20 | Initiates | → Buy | Get Alert |
| 03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Justin Walsh41% | — | Downgrade | Buy → Hold | Get Alert |
| 01/10/2024 | LNTH | Buy Now | Lantheus Holdings | $97.04 | -2.1% | Justin Walsh41% | $113 → $95 | Maintains | Buy | Get Alert |
| 11/15/2023 | CATX | Buy Now | Perspective Therapeutics | $2.38 | -41.18% | Justin Walsh41% | → $14 | Initiates | → Buy | Get Alert |
| 10/04/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Justin Walsh41% | — | Downgrade | Buy → Hold | Get Alert |
| 10/03/2023 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 16.45% | Justin Walsh41% | → $113 | Reiterates | Buy → Buy | Get Alert |
| 09/07/2023 | CTSO | Buy Now | CytoSorbents | $0.98 | 308.12% | Justin Walsh41% | → $4 | Reinstates | Buy → Buy | Get Alert |
| 09/06/2023 | PRME | Buy Now | Prime Medicine | $2.00 | 900% | Justin Walsh41% | → $20 | Initiates | → Buy | Get Alert |
| 07/17/2023 | THTX | Buy Now | Theratechnologies | $1.60 | 87.5% | Justin Walsh41% | $24 → $12 | Maintains | Buy | Get Alert |
| 05/16/2023 | VOR | Buy Now | Vor Biopharma | $0.86 | 1994.73% | Justin Walsh41% | → $18 | Initiates | → Buy | Get Alert |
| 05/11/2023 | VRAY | Buy Now | ViewRay | — | — | Justin Walsh41% | $4 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2023 | TFFP | Buy Now | TFF Pharmaceuticals | — | — | Justin Walsh41% | → $175 | Initiates | → Buy | Get Alert |
| 02/10/2023 | MYNZ | Buy Now | Mainz Biomed | $4.07 | 170.27% | Justin Walsh41% | → $440 | Initiates | → Buy | Get Alert |
| 10/07/2022 | PSTV | Buy Now | Plus Therapeutics | $1.38 | 262.32% | Justin Walsh41% | → $75 | Initiates | → Buy | Get Alert |
| 10/07/2022 | LNTH | Buy Now | Lantheus Holdings | $97.04 | 7.17% | Justin Walsh41% | → $104 | Initiates | → Buy | Get Alert |
| 09/07/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Justin Walsh41% | → $10 | Initiates | → Buy | Get Alert |
| 09/07/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Justin Walsh41% | → $22 | Initiates | → Buy | Get Alert |
| 05/20/2022 | HROW | Buy Now | Harrow Health | $30.10 | -33.55% | Justin Walsh41% | $17 → $20 | Maintains | Buy | Get Alert |
| 05/09/2022 | LNTH | Buy Now | Lantheus Holdings | $97.04 | -6.22% | Justin Walsh41% | → $91 | Initiates | → Buy | Get Alert |
| 05/04/2022 | CTSO | Buy Now | CytoSorbents | $0.98 | 512.18% | Justin Walsh41% | $7 → $6 | Maintains | Buy | Get Alert |
| 04/05/2022 | CRIS | Buy Now | Curis | $2.60 | 284.62% | Justin Walsh41% | $440 → $200 | Maintains | Buy | Get Alert |
| 01/19/2022 | CMPX | Buy Now | Compass Therapeutics | $2.12 | 371.7% | Justin Walsh41% | → $10 | Initiates | → Buy | Get Alert |
| 01/11/2022 | VRAY | Buy Now | ViewRay | — | — | Justin Walsh41% | → $7 | Upgrade | Neutral → Buy | Get Alert |
| 09/02/2021 | PRTG | Buy Now | Portage Biotech | $10.39 | 284.99% | Justin Walsh41% | → $800 | Initiates | → Buy | Get Alert |
| 03/25/2021 | VOR | Buy Now | Vor Biopharma | $0.86 | 6882.43% | Justin Walsh41% | → $60 | Initiates | → Buy | Get Alert |
| 03/25/2021 | CRIS | Buy Now | Curis | $2.60 | 630.77% | Justin Walsh41% | → $380 | Initiates | → Buy | Get Alert |
| 05/06/2020 | CTSO | Buy Now | CytoSorbents | $0.98 | 1532.49% | Justin Walsh41% | $12 → $16 | Maintains | Buy | Get Alert |
| 10/07/2016 | CTSO | Buy Now | CytoSorbents | $0.98 | — | Justin Walsh41% | — | Initiates | → Buy | Get Alert |
